Respiratory

Early evidence shows that nirsevimab substantially reduced emergency bronchiolitis cases and hospital admissions in infants under 6 months.

A large Phase III trial has found that onradivir, a novel PB2 polymerase inhibitor, significantly shortens recovery time in adults with uncomplicated influenza A.

A structured parenting programme based on acceptance and commitment therapy has shown clinical benefits in managing asthma and ADHD symptoms in children.

New findings support the integration of PET/CT prior to biopsy in patients with intermediate-to-high-risk lung nodules.

A major international trial has assessed whether nasal high-flow oxygen improves outcomes during emergency paediatric intubation.

Next-generation metagenomic sequencing has uncovered key differences in bronchiectasis pathogens and resistance genes across Europe.

Machine learning models using data from digital inhalers can successfully predict COPD exacerbations up to 5 days in advance.

New research suggests that early impairment in mucosal IgA immunity may contribute to the later development of bronchiolitis obliterans syndrome in lung transplant recipients.